• 14 December 2006
  • News
  • By

BioSuppliers News

Seminar on quality control in clinical labs

Seminar on quality control in clinical labs

Bio-Rad Laboratories, in association with Quality Council of India (QCI), had organized a seminar on quality control in clinical laboratories to bring awareness on the dire need to upgrade testing and diagnostic facilities in the country and also spread consciousness amongst the general public on the damage that unaccredited and rudimentary laboratories can cause them.

The seminar focused on need for upgrading and maintaining laboratory quality, data management of quality control and laboratory accreditation ISO 15189. Dr Venkatesh Thuppil, who is a lead assessor with the National Accreditation Board for Testing and Calibration Laboratories (NABL) said, "Laboratories must follow required quality assurance procedures based on the internationally accepted statistical methodologies. Out of over 100,000 Laboratories in India, less than 100 Laboratories are accredited, a dismally low figure for a country which is amongst the fastest developing in the world".

The seminar saw presentations by Greg Cooper, manager, clinical standards and practices and Jeff Larson, senior product manager, Bio-Rad USA.

 

Bio-Rad's test kits for HIV and Hepatitis

Bio-Rad India has launched new ULTRA test kits for HIV, Hepatitis B & C virus in the Indian market. These kits have been developed by Bio-Rad in association with the Pasteur Institute of France. The HIV and Hepatitis test kits shall be marketed under the brand name of Genscreen HIV ULTRA Ag-Ab, HBsAg Ultra and Monolisa HCV ULTRA Ag-Ab respectively. The new generation kit is most advanced in its segment, thanks to its antigen detection ability.

 

TNT acquires Speedage in domestic express market in India

TNT NV has announced the acquisition of ARC India, which operates under the trade name Speedage Express Cargo Services, one of the leading road express companies in India.

This acquisition is a key component of TNT's focus on networks strategy as announced in December 2005. Acquiring Speedage is in line with TNT's strategic objective to become the leading provider of express deliveries in the emerging markets in Asia, specifically India. Combining Speedage's strong domestic road network with TNT's international and domestic networks will form a powerful platform for further expansion in the fast growing Indian express market.

Founded in 1995 and with an annual profitable turnover of €17 million in FY 2005-06, Speedage has a strong and impressive list of customers, which includes global players, large and medium sized companies. This acquisition will add 514 depots, 26 transit hubs, 730 vehicles and 1,195 employees (and approx. 1,300 sub-contracted staff) to TNT's existing resources enabling TNT to offer a comprehensive network covering all parts of India.

 

SAP NetWeaver Fund makes investment in ArisGlobal

Delivering on its commitment to help customers and partners experience the business value of enterprise service-oriented architecture (enterprise SOA), SAP AG has made a minority investment in ArisGlobal Holdings LLC (ArisGlobal), a provider of pharmacovigilance and safety, registration information management, clinical trials management and medical communications software solutions to the pharmaceutical, biotechnology, medical device and clinical research organization (CRO) markets.

This marks the second investment for SAP's $125 million global SAP NetWeaver Fund and underscores SAP's commitment to fuel the development of innovative solutions built on the SAP NetWeaver platform. The announcement was made at the EMEA Enterprise Services Partner Summit, being held in Amsterdam.

ArisGlobal software helps companies meet international regulatory requirements.

"As part of the SAP ecosystem, ArisGlobal is committed to delivering innovative solutions that take advantage of the SAP NetWeaver platform," said Deepak Abbhi, CEO of ArisGlobal.

 

VWR International opens subsidiary in Bangalore

VWR International has announced the establishment of a full-service, wholly owned subsidiary called VWR Lab Products in Bangalore and branch office in Mumbai, to better serve the needs of the rapidly expanding pharmaceutical and biotech industry in the subcontinent.

The new subsidiary will serve as a central resource for customer service, sales support and technical services for the Indian subcontinent. As a fully licensed Indian company, VWR Lab Products will hire locally and conduct transactions in local currency, offering an added convenience for VWR's global customers. It will continue to serve as a location for VWR's strategic sourcing of laboratory supplies, equipment and instruments within India.

"India is a growth market for VWR and has traditionally lacked a one-stop-shop provider for laboratory products with the capability to offer everything from consumables to instruments. VWR will now fill that void and help create procurement efficiencies along with global product standardization in terms of range and quality," said MK Sathya, MD, India Operations, VWR Lab Products and vice president, global sourcing, VWR, International, USA.

Sharing his thoughts, Kevin Leak, senior vice president of strategic sourcing and category management, VWR International, USA said, "Coupled with the rapidly expanding domestic pharmaceutical and biotech industry in the Indian subcontinent, this presents a tremendous opportunity for VWR to meet the needs of our existing customers and to tap into new market growth, while supporting VWR's overall strategy of geographic expansion with first-class local service for our customers."

 

HiMedia launches a line of 14 vegetable-based peptones

HiMedia Laboratories has launched a line of 14 vegetable-based peptones matching the performances of all the traditional animal/bovine based peptones.

Dr GM Warke, CEO, HiMedia Laboratories, said, "The initial reaction amongst the biopharmaceutical community globally has been very encouraging. This also has been widely acknowledged as a vital breakthrough."

He further said, "The present decade has shown tremendous growth and investment in the pharmaceutical sector in India as well as globally. The growth potential observed pertains mainly to regulated markets. Several Indian biopharma companies are at the sourcing end for these markets, and these are the ones that require quality assured, consistent and cost effective raw material supplies with various quality systems and certification program. HiMedia is in a sound position to cater to this market."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X